Tuzun, E. Et Al. 2005. Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment. JOURNAL OF AUTOIMMUNITY , vol.24, no.3 , 261-268.

Tuzun, E., MERIGGIOLI, M., ROWIN, J., YANG, H., & CHRISTADOSS, P., (2005). Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment. JOURNAL OF AUTOIMMUNITY , vol.24, no.3, 261-268.

Tuzun, Erdem Et Al. "Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment," JOURNAL OF AUTOIMMUNITY , vol.24, no.3, 261-268, 2005

Tuzun, Erdem Et Al. "Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment." JOURNAL OF AUTOIMMUNITY , vol.24, no.3, pp.261-268, 2005

Tuzun, E. Et Al. (2005) . "Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment." JOURNAL OF AUTOIMMUNITY , vol.24, no.3, pp.261-268.

@article{article, author={Erdem TÜZÜN Et Al. }, title={Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment}, journal={JOURNAL OF AUTOIMMUNITY}, year=2005, pages={261-268} }